20 Stocks Insiders Were Buying In Q1 2025

10. The Oncology Institute, Inc. (NASDAQ:TOI)

Market Cap: $100.05 million

Number of insiders buying: 8

The Oncology Institute ranks tenth among the 20 stocks that insiders are buying in Q1 2025. It provides medical oncology services in the United States, focusing on adult and senior cancer patients. The company offers a range of services, including physician care, infusion, clinical trials, radiation, and patient support. It also collaborates with Healthy Forge to deliver cancer care services in Southern California.

In a recent development, the company launched the Florida Oncology Network, a fully delegated network aimed at expanding access to high-quality cancer care for Florida residents. The network, which includes TOI Clinics and a panel of oncologists, partners with Provider Network Solutions to enhance care coordination, improve patient outcomes, and expand its reach across the state in 2025.

Dan Virnich, CEO of TOI, stated, “I’m very excited about the launch of Florida Oncology Network and our continued rapid growth in capitated lives in Q1.

For the fourth quarter of 2024, The Oncology Institute reported revenue of $100 million, an increase of 16.9% compared to the prior-year quarter. Gross profit amounted to $15 million, up 1.8% from the same period of 2023. Net loss was $13.2 million, which compares to net loss of $18.8 million in the corresponding quarter of the prior year.

In March, eight insiders, including the company’s CEO, CMO, and COO, acquired a total of around $1.61 million worth of The Oncology Institute shares at an average price of $1.04 per share. Year-to-date the stock is up 277.58% trading at $1.17 per share. However, over the past 12 months, the Oncology Institute shares dropped 24.97%.

Currently, the analyst coverage on The Oncology Institute stock is limited.